Literature DB >> 4726832

Evaluation of streptozyme and antistreptolysin O tests in streptococcal pyodermal nephritis.

S Bergner-Rabinowitz, I Ofek, S Fleiderman, M Zohar, K Rabinowitz, I Ginsburg.   

Abstract

The evaluation of the streptozyme test in sera from 34 patients with streptococcal pyodermal nephritis was studied. Ninety-seven percent of the patients developed high titers of antistreptozyme antibodies on the first bleeding after hospitalization, in contrast to only 40% of patients who developed elevated antistreptolysin O titers. The high antistreptozyme titers declined during convalescence and reached normal levels in the sixth month after onset of the disease. The most significant fall in titers occurred between 1 and 2 months from the onset of disease. The streptozyme test may be particularly helpful as a rapid screening test for antibodies in streptococcal pyodermal nephritis.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4726832      PMCID: PMC379716          DOI: 10.1128/am.26.1.56-58.1973

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  11 in total

Review 1.  Streptococcal skin infection and acute glomerulonephritis.

Authors:  H C Dillon
Journal:  Postgrad Med J       Date:  1970-11       Impact factor: 2.401

Review 2.  Differences between streptococcal infections of the throat and of the skin (second of two parts).

Authors:  L W Wannamaker
Journal:  N Engl J Med       Date:  1970-01-08       Impact factor: 91.245

3.  Type-specific streptococcal antibodies in pyodermal nephritis.

Authors:  S Bergner-Rabinowitz; I Ofek; M A Davies; K Rabinowitz
Journal:  J Infect Dis       Date:  1971-11       Impact factor: 5.226

4.  Epidemic glomerulonephritis in Israel.

Authors:  E E Lasch; V Frankel; P A Vardy; S Bergner-Rabinowitz; I Ofek; K Rabinowitz
Journal:  J Infect Dis       Date:  1971-08       Impact factor: 5.226

5.  Streptococcal infections and epidemic acute glomerulonephritis in South Trinidad.

Authors:  E V Potter; A C Siegel; N M Simon; J McAninch; D P Earle; T Poon-King; I Mohommed; S Abidh
Journal:  J Pediatr       Date:  1968-06       Impact factor: 4.406

6.  Micro antistreptolysin O test.

Authors:  G C Klein; M D Moody; C N Baker; B V Addison
Journal:  Appl Microbiol       Date:  1968-01

7.  Streptococcal types in Israel hospitals. A four-year study.

Authors:  S Bergner-Rabinowitz; O Sklut; E Haimowici; A M Davies
Journal:  Isr J Med Sci       Date:  1966 Jul-Aug

8.  Serum antibodies to streptococci in rheumatic fever, glomerulonephritis and chorea.

Authors:  L W Wannamaker
Journal:  Zentralbl Bakteriol Orig       Date:  1970

9.  Comparison of the streptozyme test with the antistreptolysin O, antideoxyribonuclease B, and antihyaluronidase tests.

Authors:  G C Klein; W L Jones
Journal:  Appl Microbiol       Date:  1971-02

10.  Skin infections and acute nephritis in American Indian children.

Authors:  B F Anthony; L V Perlman; L W Wannamaker
Journal:  Pediatrics       Date:  1967-02       Impact factor: 7.124

View more
  5 in total

1.  Antigens of group A streptococci involved in passive hemagglutination reactions.

Authors:  A L Bisno; I Ofek; E H Beachey
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

2.  Immune response to extracellular and somatic antigens in streptococcal infection and sequelae.

Authors:  S Bergner-Rabinowitz; M Ferne; H Karshai
Journal:  Inflammation       Date:  1979-09       Impact factor: 4.092

3.  Specificity and sensitivity of the streptozyme test for the detection of streptococcal antibodies.

Authors:  A el-Kholy; K Hafez; R M Krause
Journal:  Appl Microbiol       Date:  1974-04

4.  Circulating immune complexes and complement levels in relation to the clinical presentation of Nigerian children with acute poststreptococcal glomerulonephritis.

Authors:  I I Onyewotu; J Mee
Journal:  J Clin Pathol       Date:  1978-09       Impact factor: 3.411

5.  Heterogeneity of type-specific and cross-reactive antigenic determinants within a single M protein of group A streptococci.

Authors:  J B Dale; I Ofek; E H Beachey
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.